These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

205 related items for PubMed ID: 24465704

  • 1. Ologen implant versus mitomycin C for trabeculectomy: a systematic review and meta-analysis.
    He M, Wang W, Zhang X, Huang W.
    PLoS One; 2014; 9(1):e85782. PubMed ID: 24465704
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Comparison of outcomes of trabeculectomy with mitomycin C vs. ologen implant in primary glaucoma.
    Senthil S, Rao HL, Babu JG, Mandal AK, Garudadri CS.
    Indian J Ophthalmol; 2013 Jul; 61(7):338-42. PubMed ID: 23571259
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Using a collagen matrix implant (Ologen) versus mitomycin-C as a wound healing modulator in trabeculectomy with the Ex-PRESS mini glaucoma device: a 12-month retrospective review.
    Johnson MS, Sarkisian SR.
    J Glaucoma; 2014 Dec; 23(9):649-52. PubMed ID: 24240882
    [Abstract] [Full Text] [Related]

  • 6. Efficacy and Safety of Ologen Implant Versus Mitomycin C in Primary Trabeculectomy: A Meta-analysis of Randomized Clinical Trials.
    Ji Q, Qi B, Liu L, Guo X, Zhong J.
    J Glaucoma; 2015 Dec; 24(5):e88-94. PubMed ID: 25264995
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Biodegradable collagen matrix implant vs mitomycin-C as an adjuvant in trabeculectomy: a 24-month, randomized clinical trial.
    Cillino S, Di Pace F, Cillino G, Casuccio A.
    Eye (Lond); 2011 Dec; 25(12):1598-606. PubMed ID: 21921953
    [Abstract] [Full Text] [Related]

  • 9. Tube Shunt Revision With Excision of Fibrotic Capsule Using Mitomycin C With and Without Ologen-a Collagen Matrix Implant: A 3-Year Follow-up Study.
    Salimi A, Kovalyuk N, Harasymowycz PJ.
    J Glaucoma; 2019 Nov; 28(11):989-996. PubMed ID: 31567908
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Biodegradable collagen matrix implant versus mitomycin-C in trabeculectomy: five-year follow-up.
    Cillino S, Casuccio A, Di Pace F, Cagini C, Ferraro LL, Cillino G.
    BMC Ophthalmol; 2016 Mar 05; 16():24. PubMed ID: 26946419
    [Abstract] [Full Text] [Related]

  • 12. Trabeculectomy with OloGen versus Mitomycin C for the Treatment of Silicone Oil-Induced Glaucoma.
    Shalaby HS, Hashem NH.
    Klin Monbl Augenheilkd; 2022 Sep 05; 239(9):1147-1154. PubMed ID: 34198351
    [Abstract] [Full Text] [Related]

  • 13. Intraoperative mitomycin C versus intraoperative 5-fluorouracil for trabeculectomy: a systematic review and meta-analysis.
    Lin ZJ, Li Y, Cheng JW, Lu XH.
    J Ocul Pharmacol Ther; 2012 Apr 05; 28(2):166-73. PubMed ID: 22029538
    [Abstract] [Full Text] [Related]

  • 14. Outcomes of Trabeculectomy and Phacotrabeculectomy With Collagen Matrix Implant (Ologen) and Low-dose Mitomycin C: 2-Year Follow-up.
    Castejón MA, Teus MA, Bolivar G, Paz-Moreno-Arrones J, Castaño B.
    J Glaucoma; 2018 Jan 05; 27(1):50-54. PubMed ID: 29117004
    [Abstract] [Full Text] [Related]

  • 15. Subscleral trabeculectomy with mitomycin-C versus ologen for treatment of glaucoma.
    Marey HM, Mandour SS, Ellakwa AF.
    J Ocul Pharmacol Ther; 2013 Apr 05; 29(3):330-4. PubMed ID: 23113645
    [Abstract] [Full Text] [Related]

  • 16. Ologen implant versus mitomycin C in combined trabeculectomy and phacoemulsification.
    Paul C, Divya J, Kamal R, Paul A.
    Indian J Ophthalmol; 2022 Apr 05; 70(4):1248-1252. PubMed ID: 35326026
    [Abstract] [Full Text] [Related]

  • 17. Comparison of the Outcomes of Trabeculectomy with 5-Fluorouracil versus Ologen Implant in Primary Open-Angle Glaucoma.
    Shihadeh W, Massad I, Khader Y, Al-Rawi A, Alshalakhti T.
    Ophthalmic Res; 2017 Apr 05; 58(2):94-98. PubMed ID: 28468021
    [Abstract] [Full Text] [Related]

  • 18. Outcome of trabeculectomy with Ologen versus Mitomycin C: A comparative prospective study in Bangladesh.
    Sarker BK, Abdullahi SM, Hassan Z, Kabir J, Badmus S, Alam S, Rahman M, Malek MI, Mahatma M.
    Eur J Ophthalmol; 2019 Mar 05; 29(2):183-188. PubMed ID: 29701072
    [Abstract] [Full Text] [Related]

  • 19. Outcomes of Trabeculectomy Augmented With Subconjunctival and Subscleral Ologen Implantation in Primary Advanced Glaucoma.
    Angmo D, Wadhwani M, Upadhyay AD, Temkar S, Dada T.
    J Glaucoma; 2017 Jan 05; 26(1):8-14. PubMed ID: 27599174
    [Abstract] [Full Text] [Related]

  • 20. Ex-PRESS outcomes using mitomycin-C, Ologen alone, Ologen with 5-fluorouracil.
    Menda SA, Lowry EA, Porco TC, Stamper RL, Rubin MR, Han Y.
    Int Ophthalmol; 2015 Jun 05; 35(3):357-63. PubMed ID: 24920197
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.